< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 61
- Overcoming resistance to anti-PD1 blockade in uterine leiomyosarcomasFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Post-mortem tissue biobanking to illuminate end-stage ovarian cancer disease (ATLASOvCANCER)From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advisory Board Cancer Infertility Pregnancy (ABCIP)From1 Jan 2023 → 31 Dec 2023Funding: Other federal public and semi-governmental institutions
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Impact of prenatal exposure to cancer treatment during pregnancy and of chemotherapy for breast cancer on the brains: a multimodal MR imaging studyFrom1 Dec 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 584
- Surgical flap delay to allow primary transabdominal transplantation of extended rectus abdominis myocutaneous flaps in increasingly complex pelvic wound reconstructions(2023)
Authors: Frédéric Amant
Pages: 393 - 398 - Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study(2023)
Authors: Ann Belmans, Kris Bogaerts, Regina Esi Mensimah Baiden-Amissah, Diether Lambrechts, Frédéric Amant
Pages: 475 - 491 - A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature(2023)
Authors: Frédéric Amant
- Postpartum breast cancer diagnosed during the post-weaning period: a distinct entity with unique clinicopathological, molecular and immunological features?(2023)
Authors: Hanne Lefrere, Frédéric Amant, Diether Lambrechts, Liesbeth Lenaerts
- Characterization of the genotoxic profile of antineoplastic drugs using the cytokinesis-block micronucleus cytome assay(2023)
Authors: Ilana Struys, Eline Verscheure, Liesbeth Lenaerts, Frédéric Amant, Lode Godderis, Manosij Ghosh
- Psychological impact of referral to an oncology hospital on patients with an ovarian mass(2023)
Authors: Frédéric Amant
Pages: 74 - 82 - An Algorithm for Labia Minora Reduction Based on a Review of Anatomical, Configurational, and Individual Considerations(2023)
Authors: Frédéric Amant
Pages: 17 - 25 - Impact of chemotherapy during pregnancy on fetal growth(2022)
Authors: Charlotte Maggen, Kristel Van Calsteren, Annouschka Laenen, Joosje Heimovaara, Frédéric Amant
Pages: 10314 - 10323 - Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer(2022)
Authors: Frédéric Amant
- Serine auxotrophy: a novel metabolic vulnerability of platinum resistant ovarian cancers?(2022)
Authors: Tom Van Nyen, Frédéric Amant, Daniela Annibali, Sarah-Maria Fendt